Isoproterenol inhibits angiotensin II-stimulated proliferation and reactive oxygen species production in vascular smooth muscle cells through heme oxygenase-1

Biological and Pharmaceutical Bulletin

Volumn 32, Issue 6, 2009, Pages 1047-1052

  Kim, Jung Eun ^a   Kang, Young Jin ^a   Lee, Kwang Youn ^a   Choi, Hyoung Chul ^a  

^a Yeungnam University College of Medicine   (South Korea)

Author keywords

2 adrenoceptor; Angiotensin II; Heme oxygenase 1; Isoproterenol; Reactive oxygen species

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; ANGIOTENSIN II; BUTOXAMINE; HEME OXYGENASE 1; ISOPRENALINE; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; N [2 (4 BROMOCINNAMYLAMINO)ETHYL] 5 ISOQUINOLINESULFONAMIDE; PROTOPORPHYRIN TIN; REACTIVE OXYGEN METABOLITE;

ANIMAL CELL; AORTA; ARTICLE; BETA ADRENERGIC RECEPTOR BLOCKING; CELL PROLIFERATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; DRUG INHIBITION; DRUG MECHANISM; NONHUMAN; PROTEIN EXPRESSION; PROTEIN INDUCTION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; SMOOTH MUSCLE FIBER; VASCULAR SMOOTH MUSCLE;

ADRENERGIC BETA-AGONISTS; ANGIOTENSIN II; ANIMALS; AORTA; BLOTTING, WESTERN; CELL PROLIFERATION; CELLS, CULTURED; CYCLIC AMP-DEPENDENT PROTEIN KINASES; DOSE-RESPONSE RELATIONSHIP, DRUG; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; HEME OXYGENASE (DECYCLIZING); ISOPROTERENOL; MALE; MUSCLE, SMOOTH, VASCULAR; PHOSPHORYLATION; RATS; RATS, SPRAGUE-DAWLEY; REACTIVE OXYGEN SPECIES; RECEPTORS, ADRENERGIC, BETA-2; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 66549126324     PISSN: 09186158     EISSN: 13475215     Source Type: Journal    
DOI: 10.1248/bpb.32.1047     Document Type: Article

References (28)

1. Touyz R. M., Schiffrin E. L., Pharmacol. Rev., 52, 639-672 (2000).
2. Griendling K. K., Ollerenshaw J. D., Minieri C. A., Alexander R. W., Circ. Res., 74, 1141-1148 (1994).
3. Rajagopalan S., Kurz S., Munzel T., Tarpey M., Freeman B. A., Griendling K. K., Harrison D. G., J. Clin. Invest., 97, 1916-1923 (1996).
4. Berliner J. A., Heinecke J. W., Free Radic. Biol. Med., 20, 707-727 (1996).
5. Werstiuk E. S., Lee R. M., Can. J. Physiol. Pharmacol., 78, 433-452 (2000).
6. El-Hajj H., Oriowo M. A., Life Sci., 79, 592-597 (2006).
7. Matsushita M., Tanaka Y., Koike K., J. Smooth Muscle Res., 42, 217-225 (2006).
8. Immenschuh S., Kietzmann T., Hinke V., Wiederhold M., Katz N., Muller E. U., Mol. Pharmacol., 53, 483-491 (1998).
9. Duckers H. J., Boehm M., True A. L., Yet S. F., San H., Park J. L., Clinton Webb R., Lee M. E., Nabel G. J., Nabel E. G., Nat. Med., 7, 693-698 (2001).
10. Liu X. M., Chapman G. B., Wang H., Durante W., Circulation, 105, 79-84 (2002).
11. Zhang M., Zhang B. H., Chen L., An W., Cell Res., 12, 123-132 (2002).
12. Zhang M., An W., Du H. J., Chen L., Sheng Li Xu Bao, 54, 12-16 (2002).
13. Iles K. E., Dickinson D. A., Wigley A. F., Welty N. E., Blank V., Forman H. J., Free Radic. Biol. Med., 39, 355-364 (2005).
14. Ryter S. W., Choi A. M., Antioxid. Redox Signal., 7, 80-91 (2005).
15. Weber H., Taylor D. S., Molloy C. J., J. Clin. Invest., 93, 788-798 (1994).
16. Touyz R. M., He G., Wu X. H., Park J. B., Mabrouk M. E., Schiffrin E. L., Hypertension, 38, 56-64 (2001).
17. Koyama H., Olson N. E., Dastvan F. F., Reidy M. A., Circ. Res., 82, 713-721 (1998).
18. Matrougui K., Eskildsen-Helmond Y. E., Fiebeler A., Henrion D., Levy B. I., Tedgui A., Mulvany M. J., Hypertension, 36, 617-621 (2000).
19. Muthalif M. M., Karzoun N. A., Gaber L., Khandekar A., Benter I. F., Saeed A. E., Parmentier J. H., Estes A., Malik K. U., Hypertension, 36, 604-609 (2000).
20. Garcha R. S., Sever P. S., Hughes A. D., Br. J. Pharm., 134, 188-196 (2001).
21. Schwer C. I., Guerrero A. M., Humar M., Roesslein M., Goebel U., Stoll P., Geiger K. K., Pannen B. H., Hoetzel A., Schmidt R., J. Pharmacol. Exp. Ther., 327, 863-871 (2008).
22. Touyz R. M., Schiffrin E. L., J. Hypertens., 19, 1245-1254 (2001).
23. Seshiah P. N., Weber D. S., Rocic P., Valppu L., Taniyama Y., Griendling K. K., Circ. Res., 91, 406-413 (2002).
24. Laufs U., Adam O., Strehlow K., Wassmann S., Konkol C., Laufs K., Schmidt W., Bohm M., Nickenig G., J. Biol. Chem., 278, 5956-5962 (2003).
25. Frank G. D., Eguchi S., Yamakawa T., Tanaka S., Inagami T., Motley E. D., Endocrinology, 141, 3120-3126 (2000).
26. Sano M., Fukuda K., Sato T., Kawaguchi H., Suematsu M., Matsuda S., Koyasu S., Matsu H., Yamauchi-Takihara K., Harada M., Saito Y., Ogawa S., Circ. Res., 89, 661-669 (2001).
27. Kyaw M., Yoshizumi M., Tsuchiya K., Kirima K., Tamaki T., Hypertens. Res., 24, 251-261 (2001).
28. Laplante M. A., Wu R., El Midaoui A., de Champlain J., J. Hypertens., 21, 927-936 (2003).